Skip Nav Destination
Issues
15 June 2020
-
Cover Image
Cover Image
The cover shows intravital imaging of living mouse brain (courtesy of S. Rivest and P. Préfontaine, Laval University) 5 days after intravenous administration of an LRP-1 binding peptide, Angiopep-2 that has been conjugated with a fluorescent tag that appears green. The imaging shows significant extravascular accumulation of the peptide in the brain meninges (top) and parenchyma, demonstrating its passage across the blood-brain and blood-CSF barriers. For details, see the article by Kumthekar and colleagues on page 2789 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Review
Perspectives
Clinical Trials: Targeted Therapy
Author Choice
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar; Shou-Ching Tang; Andrew J. Brenner; Santosh Kesari; David E. Piccioni; Carey Anders; Jose Carrillo; Pavani Chalasani; Peter Kabos; Shannon Puhalla; Katherine Tkaczuk; Agustin A. Garcia; Manmeet S. Ahluwalia; Jeffrey S. Wefel; Nehal Lakhani; Nuhad Ibrahim
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
Anfal Alsadhan; Jean Cheung; Michael Gulrajani; Erika M. Gaglione; Pia Nierman; Ahmed Hamdy; Raquel Izumi; Elena Bibikova; Priti Patel; Clare Sun; Todd Covey; Sarah E.M. Herman; Adrian Wiestner
Author Choice
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia
Alexey V. Danilov; Charles Herbaux; Harriet S. Walter; Peter Hillmen; Simon A. Rule; Ebenezer A. Kio; Lionel Karlin; Martin J.S. Dyer; Siddhartha S. Mitra; Ping Cheng Yi; Rita Humeniuk; Xi Huang; Ziqian Zhou; Pankaj Bhargava; Juliane M. Jürgensmeier; Christopher D. Fegan
Author Choice
A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
Monica M. Mita; Patricia M. LoRusso; Kyriakos P. Papadopoulos; Michael S. Gordon; Alain C. Mita; Roberta Ferraldeschi; Harold Keer; Aram Oganesian; Xiang Yao Su; Simone Jueliger; Anthony W. Tolcher
Clinical Trials: Immunotherapy
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
Alain P. Algazi; Christopher G. Twitty; Katy K. Tsai; Mai Le; Robert Pierce; Erica Browning; Reneta Hermiz; David A. Canton; Donna Bannavong; Arielle Oglesby; Murray Francisco; Lawrence Fong; Mikael J. Pittet; Sean P. Arlauckas; Christopher Garris; Lauren P. Levine; Carlos Bifulco; Carmen Ballesteros-Merino; Shailender Bhatia; Sharron Gargosky; Robert H.I. Andtbacka; Bernard A. Fox; Michael D. Rosenblum; Adil I. Daud
Precision Medicine and Imaging
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring; Geoffrey Fell; Andrea Arfe; Chandni Sharma; Rachel Greenup; Kerry L. Reynolds; Barbara L. Smith; Brian Alexander; Beverly Moy; Steven J. Isakoff; Giovanni Parmigiani; Lorenzo Trippa; Aditya Bardia
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
Matthew D. Hellmann; Barzin Y. Nabet; Hira Rizvi; Aadel A. Chaudhuri; Daniel K. Wells; Mark P.S. Dunphy; Jacob J. Chabon; Chih Long Liu; Angela B. Hui; Kathryn C. Arbour; Jia Luo; Isabel R. Preeshagul; Everett J. Moding; Diego Almanza; Rene F. Bonilla; Jennifer L. Sauter; Hyejin Choi; Megan Tenet; Mohsen Abu-Akeel; Andrew J. Plodkowski; Rocio Perez Johnston; Christopher H. Yoo; Ryan B. Ko; Henning Stehr; Linda Gojenola; Heather A. Wakelee; Sukhmani K. Padda; Joel W. Neal; Jamie E. Chaft; Mark G. Kris; Charles M. Rudin; Taha Merghoub; Bob T. Li; Ash A. Alizadeh; Maximilian Diehn
The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Maximilian Linxweiler; Fengshen Kuo; Nora Katabi; Mark Lee; Zaineb Nadeem; Martin G. Dalin; Vladimir Makarov; Diego Chowell; Snjezana Dogan; Ian Ganly; A. Ari Hakimi; Richard J. Wong; Nadeem Riaz; Alan L. Ho; Timothy A. Chan; Luc G.T. Morris
Author Choice
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
Suzanne J. Forrest; Alyaa Al-Ibraheemi; Duong Doan; Abigail Ward; Catherine M. Clinton; Juan Putra; R. Seth Pinches; Cigall Kadoch; Susan N. Chi; Steven G. DuBois; Patrick J. Leavey; Nicole R. LeBoeuf; Elizabeth Mullen; Natalie Collins; Alanna J. Church; Katherine A. Janeway
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group
Christine L. Phillips; Adam Lane; Robert B. Gerbing; Todd A. Alonzo; Alyss Wilkey; Gretchen Radloff; Beverly Lange; Eric R. Gamazon; M. Eileen Dolan; Stella M. Davies
Author Choice
A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ
Karuna Mittal; Michael S. Toss; Guanhao Wei; Jaspreet Kaur; Da Hoon Choi; Brian D. Melton; Remus M. Osan; Islam M. Miligy; Andrew R. Green; Emiel A.M. Janssen; Håvard Søiland; Keerthi Gogineni; Upender Manne; Padmashree Rida; Emad A. Rakha; Ritu Aneja
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
Feng Xie; Jianjun Zhang; Jiayin Wang; Alexandre Reuben; Wei Xu; Xin Yi; Frederick S. Varn; Yongsheng Ye; Junwen Cheng; Miao Yu; Yue Wang; Yufeng Liu; Mingchao Xie; Peng Du; Ke Ma; Xin Ma; Penghui Zhou; Shengli Yang; Yaobing Chen; Guoping Wang; Xuefeng Xia; Zhongxing Liao; John V. Heymach; Ignacio I. Wistuba; P. Andrew Futreal; Kai Ye; Chao Cheng; Tian Xia
Periostin and Epithelial–Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma
Maria Assunta Piano; Antonella Brunello; Rocco Cappellesso; Paola Del Bianco; Adriana Mattiolo; Chiara Fritegotto; Barbara Montini; Carolina Zamuner; Paolo Del Fiore; Marco Rastrelli; Antonio Sommariva; Gian Luca De Salvo; Maria Cristina Montesco; Carlo Riccardo Rossi; Vittorina Zagonel; Maria Luisa Calabrò
Translational Cancer Mechanisms and Therapy
MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions
Hiroki Sato; Adam J. Schoenfeld; Evan Siau; Yue Christine Lu; Huichun Tai; Ken Suzawa; Daisuke Kubota; Allan J.W. Lui; Besnik Qeriqi; Marissa Mattar; Michael Offin; Masakiyo Sakaguchi; Shinichi Toyooka; Alexander Drilon; Neal X. Rosen; Mark G. Kris; David Solit; Elisa De Stanchina; Monika A. Davare; Gregory J. Riely; Marc Ladanyi; Romel Somwar
Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
Kyle Current; Catherine Meyer; Clara E. Magyar; Christine E. Mona; Joel Almajano; Roger Slavik; Andreea D. Stuparu; Chloe Cheng; David W. Dawson; Caius G. Radu; Johannes Czernin; Katharina Lueckerath
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
Federica Ganci; Claudio Pulito; Sara Valsoni; Andrea Sacconi; Chiara Turco; Mahrou Vahabi; Valentina Manciocco; Emilia Maria Cristina Mazza; Jalna Meens; Christina Karamboulas; Anthony C. Nichols; Renato Covello; Raul Pellini; Giuseppe Spriano; Giuseppe Sanguineti; Paola Muti; Silvio Bicciato; Laurie Ailles; Sabrina Strano; Giulia Fontemaggi; Giovanni Blandino
Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations
Todd A. Aguilera; Eslam A. Elghonaimy; Hussein Shehade; Marjan Rafat; Laura Castellini; Dadi Jiang; Mihalis Kariolis; Albert C. Koong; Quynh-Thu Le; Lesley G. Ellies; Erinn B. Rankin; Edward E. Graves; Amato J. Giaccia
Author Choice
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α
James N. Ingle; Junmei Cairns; Vera J. Suman; Lois E. Shepherd; Peter A. Fasching; Tanya L. Hoskin; Ravinder J. Singh; Zeruesenay Desta; Krishna R. Kalari; Matthew J. Ellis; Paul E. Goss; Bingshu E. Chen; Bernhard Volz; Poulami Barman; Erin E. Carlson; Tufia Haddad; Matthew P. Goetz; Barbara Goodnature; Matthew E. Cuellar; Michael A. Walters; Cristina Correia; Scott H. Kaufmann; Richard M. Weinshilboum; Liewei Wang
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors
Jordan L. Kohlmeyer; Courtney A. Kaemmer; Casey Pulliam; Chandra K. Maharjan; Allison Moreno Samayoa; Heather J. Major; Kendall E. Cornick; Vickie Knepper-Adrian; Rajesh Khanna; Jessica C. Sieren; Mariah R. Leidinger; David K. Meyerholz; K.D. Zamba; Jill M. Weimer; Rebecca D. Dodd; Benjamin W. Darbro; Munir R. Tanas; Dawn E. Quelle
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Cesar A. Santa-Maria; Janelle W. Coughlin; Dipali Sharma; Mary Armanios; Amanda L. Blackford; Colleen Schreyer; Arlene Dalcin; Ashley Carpenter; Gerald J. Jerome; Deborah K. Armstrong; Madhu Chaudhry; Gary I. Cohen; Roisin M. Connolly; John Fetting; Robert S. Miller; Karen L. Smith; Claire Snyder; Andrew Wolfe; Antonio C. Wolff; Chiung-Yu Huang; Lawrence J. Appel; Vered Stearns
A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)
Stephen J. Freedland; Jenifer Allen; Aubrey Jarman; Taofik Oyekunle; Andrew J. Armstrong; Judd W. Moul; Howard M. Sandler; Edwin Posadas; Dana Levin; Emily Wiggins; Lauren E. Howard; Yuan Wu; Pao-Hwa Lin
Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
Helena Montanuy; Águeda Martínez-Barriocanal; José Antonio Casado; Llorenç Rovirosa; Maria José Ramírez; Rocío Nieto; Carlos Carrascoso-Rubio; Pau Riera; Alan González; Enrique Lerma; Adriana Lasa; Jordi Carreras-Puigvert; Thomas Helleday; Juan A. Bueren; Diego Arango; Jordi Minguillón; Jordi Surrallés
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models
Ariel L. Hernandez; Christian D. Young; Li Bian; Kelsey Weigel; Kyle Nolan; Barbara Frederick; Gangwen Han; Guanting He; G. Devon Trahan; Michael C. Rudolph; Kenneth L. Jones; Ayman J. Oweida; Sana D. Karam; David Raben; Xiao-Jing Wang
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.